76.10
+5.60
+(7.94%)
At close: January 22 at 2:59:58 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-48,262.00
-48,262.00
-30,664.00
-20,129.00
-9,379.00
Investing Cash Flow
-1,779.00
-1,779.00
7,660.00
-4,266.00
-7,532.00
Financing Cash Flow
-2,646.00
-2,646.00
-12,464.00
98,618.00
78,951.00
End Cash Position
78,427.00
78,427.00
131,114.00
166,582.00
92,359.00
Capital Expenditure
-1,517.00
-1,517.00
-7,742.00
-3,285.00
-7,918.00
Issuance of Capital Stock
--
--
--
90,000.00
80,000.00
Issuance of Debt
--
--
--
10,000.00
--
Repayment of Debt
--
--
-10,000.00
--
--
Free Cash Flow
-49,779.00
-49,779.00
-38,406.00
-23,414.00
-17,297.00
12/31/2020 - 12/29/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6872.TWO NaviFUS Corp.
28.00
+3.13%
7814.TWO HORIEN
29.95
-4.92%
7754.TWO AnnJi
32.55
0.00%
7427.TWO Great Novel Therapeutics Biotech & Medicals
32.70
-1.36%
7808.TWO BIONET TX Corp
46.00
-0.33%
4197.TWO Visgeneer Inc.
11.10
+13.50%
6696.TWO Lin BioScience, Inc.
152.00
+4.47%
6973.TWO U-Neuron Biomedical Inc
39.05
+1.69%
6652.TWO Eusol Biotech Co.,Ltd.
7.61
-2.06%
7806.TWO Gin Hwa
74.00
+4.23%